Non-Invasive Prenatal Testing
Qualifi & Qualifi Premium 24
Advanced Non-Invasive Prenatal Testing (NIPT)
Overview
Qualifi is a revolutionary non-invasive prenatal test that screens for chromosomal abnormalities in the fetus from as early as 10 weeks of pregnancy. Using cutting-edge next-generation sequencing technology, Qualifi analyzes cell-free fetal DNA from a simple maternal blood draw — no risk to mother or baby.
99.9%
Accuracy
5–7 Days
Results In
10+
From Week
Non-Invasive
Safety
Conditions Screened
Down Syndrome (Trisomy 21)
The most common chromosomal abnormality associated with intellectual disability
Edwards Syndrome (Trisomy 18)
A serious chromosomal condition affecting multiple organ systems
Patau Syndrome (Trisomy 13)
A rare but severe chromosomal disorder
Sex Chromosome Abnormalities
Including Turner syndrome and Klinefelter syndrome
Microdeletions (Premium 24)
22q11.2 deletion syndrome and other microdeletion syndromes
All 24 Chromosomes
Comprehensive screening across all chromosomes (Premium 24)
How It Works
Consult
Meet with your doctor or our genetic counselor to discuss the test
Blood Draw
A simple blood sample is collected — takes only a few minutes
Lab Analysis
Your sample is processed in our state-of-the-art laboratory
Results
Receive your results within 5–7 business days with counseling support
Frequently Asked Questions
Is the test safe for my baby?
How early can I take the test?
What is the difference between Qualifi and Qualifi Premium 24?
How accurate are the results?
What happens if the result is positive?
Ready for Qualifi Screening?
Consult with our experts to learn more about your testing options
Book a Consultation